scholarly journals The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: executive summary

Eye ◽  
2017 ◽  
Vol 32 (1) ◽  
pp. 44-48 ◽  
Author(s):  
S Rauz ◽  
S-Y Koay ◽  
B Foot ◽  
S B Kaye ◽  
F Figueiredo ◽  
...  
Keyword(s):  
Royal College ◽  
Ocular Surface ◽  
Ocular Surface Disease ◽  
Eye Drops ◽  
Executive Summary ◽  
Serum Eye Drops

Efficacy of 2-Month Treatment With Cord Blood Serum Eye Drops in Ocular Surface Disease

Cornea ◽  
2017 ◽  
Vol 36 (8) ◽  
pp. 915-921 ◽  
Author(s):  
Giuseppe Giannaccare ◽  
Marina Buzzi ◽  
Michela Fresina ◽  
Claudio Velati ◽  
Piera Versura
Keyword(s):  
Blood Serum ◽  
Cord Blood ◽  
Ocular Surface ◽  
Ocular Surface Disease ◽  
Eye Drops ◽  
Cord Blood Serum ◽  
Serum Eye Drops

scholarly journals Evaluation of the Efficacy of 50% Autologous Serum Eye Drops in Different Ocular Surface Pathologies

2014 ◽  
Vol 2014 ◽  
pp. 1-11 ◽  
Author(s):  
Francesco Semeraro ◽  
Eliana Forbice ◽  
Osvaldo Braga ◽  
Alessandro Bova ◽  
Attilio Di Salvatore ◽  
...  
Keyword(s):  
Ocular Surface ◽  
Conventional Therapy ◽  
Keratoconjunctivitis Sicca ◽  
Signs And Symptoms ◽  
Autologous Serum ◽  
Eye Drops ◽  
Blurred Vision ◽  
Group 2 ◽  
Serum Eye Drops ◽  
Group 1

Purpose. This study evaluated the efficacy of 50% autologous serum eye drops in ocular surface diseases not improved by conventional therapy.Methods. We analyzed two groups: (1) acute eye pathologies (e.g., chemical burns) and (2) chronic eye pathologies (e.g., recurrent corneal erosion, neurotropic keratitis, and keratoconjunctivitis sicca). The patients were treated for surface instability after conventional therapy. The patients received therapy 5 times a day until stabilization of the framework; they then reduced therapy to 3 times a day for at least 3 months. We analyzed the best corrected visual acuity, epithelial defects, inflammation, corneal opacity, and corneal neovascularization. We also analyzed symptoms such as tearing, burning, sense of foreign body or sand, photophobia, blurred vision, and difficulty opening the eyelids.Results. We enrolled 15 eyes in group 1 and 11 eyes in group 2. The average therapy period was 16 ± 5.86 weeks in group 1 and 30.54 ± 20.33 weeks in group 2. The epithelial defects all resolved. Signs and symptoms improved in both groups. In group 2, the defect recurred after the suspension of therapy in 2 (18%) patients; in group 1, no defects recurred.Conclusions. Autologous serum eye drops effectively stabilize and improve signs and symptoms in eyes previously treated with conventional therapy.

Sign in / Sign up

Export Citation Format

Share Document